Skip to main content
. 2025 Jan 13;15:1463027. doi: 10.3389/fendo.2024.1463027

Table 3.

Subgroup analysis.

Outcomes Dose No. of studies Heterogeneity SMD(95%CI) P Value
I2 P
C-reactive protein < 500 mg 2 99.2% < 0.0001 -4.88(-11.72, 1.96) 0.162
≥ 500mg 5 89.7% < 0.0001 -0.18(-0.88, 0.53) 0.626
Interleukin-6 < 500 mg 3 99% < 0.0001 -2.20(-5.12, 0.71) 0.140
≥ 500mg 2 0 0.7 -0.19(-0.50, 0.12) 0.220

SMD, Standard mean difference; CI, Confidence interval